Massachusetts Mental Health Inpatient Licensing: DMH Requirements

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Massachusetts Mental Health Inpatient Licensing: DMH Psychiatric Facilities

Mental health and substance use disorder licensing run through entirely different departments in Massachusetts, and that split matters most at the residential level. Where BSAS handles round-the-clock SUD care under 105 CMR 164, psychiatric facilities are licensed by the Department of Mental Health under M.G.L. c. 19, § 19 and 104 CMR 27. Those rules define the facilities DMH licenses as private psychiatric hospitals, psychiatric units in general hospitals and intensive residential treatment programs for adolescents.

Correction (October 2026): an earlier version described DMH as licensing adult residential treatment centers and said new residential facilities generally trigger Determination of Need review. Both statements went further than the regulations, and the sections below have been corrected.

Don’t assume one license covers both

A facility can be fully DMH-licensed for residential mental health treatment and have no authority whatsoever to provide SUD services, and vice versa. If your population is genuinely co-occurring, a DMH-licensed facility doesn’t go after a freestanding BSAS license. Its SUD program runs through Part Three of 105 CMR 164 (164.500 onward), which covers providers that already hold a DMH or DPH license, and ends in what 105 CMR 164.005 calls a “Substance Use Disorder Treatment License for Department of Mental Health Licensed Facility.” That’s a license issued by DPH, not the “Approval” that programs inside DPH-licensed hospitals and clinics receive. That track only works if the DMH license is already correctly in place.

What DMH is actually looking for

Facility licensure under DMH follows its own governance, staffing, and facility standards separate from BSAS’s SUD-specific requirements. Facilities providing psychiatric services specifically may carry additional requirements on top of the base residential licensing standards, and psychiatric service lines aren’t automatically covered by a general residential mental health license.

Certificate of Need considerations

Determination of Need under M.G.L. c. 111, § 25C and 105 CMR 100 applies to the health care facilities defined in § 25B, hospitals and clinics among them, when a project crosses the capital expenditure minimum or makes a substantial change in service (for a health care facility that isn’t a hospital, 105 CMR 100.100 counts bed increases once they add up to more than twelve beds). Whether a given psychiatric project is covered depends on the facility type and the project, so put the question to DPH’s DoN program. This is a real, separate planning step from the DMH licensing application itself, and it’s worth confirming early, since a site and program plan built without accounting for DoN review can lose months once the gap surfaces.

Ketamine and Spravato Under a DMH License

An interpretation drawn from the DMH licensing structure described above, the separate DPH and BSAS layers and the Spravato REMS. DMH hasn’t published ketamine guidance.

This page already notes that psychiatric service lines aren’t automatically covered by a general residential mental health license, and ketamine is a good test of that point. A DMH-licensed psychiatric inpatient facility with physicians and nursing on staff can bring ketamine or Spravato in through its medical staff process. A residential treatment program licensed at a lower acuity should ask DMH whether a medical procedure like an infusion fits its license before planning on it, since the service may need its own approval.

A DMH-licensed residence gives a new ketamine patient staff who see them at breakfast the morning after a session. Those observations become the case for continuing, and the outpatient prescriber who will carry the series past discharge should be agreed on before the first dose. For co-occurring residents, ketamine isn’t an FDA-approved addiction medication, so it doesn’t belong in the SUD protocols a DMH facility submits for BSAS sign-off.

Spravato adds REMS enrollment and two hours of post-dose observation to the facility’s workload.

Where This Fits In

This covers DMH residential mental health licensure specifically. See Massachusetts Behavioral Health Licensing for the full picture.

This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

Adding SUD protocols to an existing Massachusetts DMH license?

Sources

• Massachusetts DPH, 105 CMR 164.000 (164.005 definitions of Approval and Substance Use Disorder Treatment License for Department of Mental Health Licensed Facility; 164.006 Part One scope): Licensure of Substance Use Disorder Treatment Programs (checked October 8, 2026)
• 105 CMR 164.505 (Justia mirror): Part Three scope for programs in DMH or BHCSQ licensed facilities (checked October 8, 2026)
• M.G.L. c. 19, § 19, two-year licenses for inpatient psychiatric, residential or day care services: c. 19, § 19 (checked October 8, 2026)
• Massachusetts DMH, 104 CMR 27.02 definition of Facility (Department-licensed psychiatric hospitals, psychiatric units in general hospitals, adolescent intensive residential treatment programs): 104 CMR 27.00 (checked October 8, 2026)
• Massachusetts DPH, 105 CMR 100.100 definitions of Health Care Facility, Expenditure Minimum and Substantial Change in Services: Determination of Need (checked October 8, 2026)
• Spravato REMS certification and two-hour monitoring: SPRAVATO REMS and FDA label rev. 04/2025, section 2.5: SPRAVATO prescribing information (checked October 8, 2026)
• Massachusetts DMH: Licensing Bulletin 19-01, co-occurring SUD care in DMH-licensed inpatient facilities under 104 CMR 27 (checked October 8, 2026)